M. Rybczinski

发表

Bridging INTERMACS 1 patients from VA-ECMO to LVAD via Impella 5.0: De-escalate and ambulate.

H. Reichenspurner, F. Pappalardo, E. Lubos, 2020, Journal of critical care.

Impella 5.0 therapy as a bridge-to-decision option for patients on extracorporeal life support with unclear neurological outcomes†.

S. Blankenberg, H. Reichenspurner, E. Lubos, 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Switching to Impella 5.0 decreases need for transfusion in patients undergoing temporary mechanical circulatory support.

S. Blankenberg, H. Reichenspurner, E. Lubos, 2020, Journal of critical care.